There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...
For the first time since 2017, Canadian doctors have released updated clinical guidelines for antiretroviral medications used ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
Morning Overview on MSN
Early trials hint a ‘functional cure’ for HIV is near
For the first time since HIV was identified, early human trials are starting to show what long‑imagined “drug‑free control” ...
Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...
DUBLIN--(BUSINESS WIRE)--The "HIV Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for HIV Drugs was valued at US$32.8 Billion in ...
It is beyond the scope of this article to describe all possible drug-drug interactions in persons taking HIV antiretroviral medications, but this section will identify the most frequent interactions ...
GLASGOW, United Kingdom — Viral suppression was induced in heavily pretreated patients with HIV after they received the investigational drug fostemsavir (ViiV Healthcare) for 24 weeks along with their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback